Gaucher disease (GD) is associated with mutations at the acid beta -glucosi
dase (GCase) locus and the resultant defective activity of the enzyme produ
ct, GCase is a membrane-associated glycoprotein that requires detergents fo
r extraction and phospholipid interfaces for full catalytic activity. Norma
l human fibroblasts and overexpressing transgenic cell lines mere used to e
valuate the intracellular disappearance, degradation, and secretion of huma
n GCase, including GD fibroblasts and C2C12 cells transduced with MFG-GCase
retrovirus and CHO cells stably transfected with the tetracycline transact
ivation conditional expression system (tet-CHO-GCase). Compared to HF, the
disappearance of GCase from the transgenic cells was 12-30 times greater, a
nd had degradative and secretory components. In tet-CHO-GCase cells the maj
ority of GCase was secreted, Intracellular degradation occurred in compartm
ents sensitive to monensin and brefeldin A, and the ALLN or leupeptin prote
ase inhibitors, i.e., ER, Golgi, and lysosomes, In tet-CHO-GCase cells, GCa
se degradation and secretion rates were inversely related to expression lev
el, Saponin permeabilization analyses of tet-CHO-GCase cells showed that a
majority of GCase was soluble, with a rapid disappearance via secretion and
degradation. A progressively increasing proportion of GCase became saponin
insoluble with a t(1/2) = 2-3 h. Intracellular saponin-soluble and -insolu
ble GCases were degraded with t(1/2) similar to2 and 14 h, respectively. Co
nfocal microscopy showed colocalization of glycosylated or unglycosylated G
Case with LAMP-2, an integral lysosomal membrane protein, to vesicular bodi
es. These studies show that GCase secretion was N-linked glycosylation depe
ndent, whereas sorting to and membrane attachment in the lysosome were N-li
nked glycosylation independent. (C) 2000 Academic Press.